PharmaPROP.BXL

Brussel ·KBO/BCE: BE 0804.643.803

Loading dossier…

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€883k
Fixed assets	21/28	€852k
Tangible fixed assets	22/27	€852k
Current assets	29/58	€31k
Amounts receivable within one year	40/41	€24k
Cash & bank	54/58	€8k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€883k
Equity	10/15	€-1k
Contributions / capital	10/11	€1k
Accumulated profits (losses)	14	€-2k
Amounts payable	17/49	€884k
Amounts payable after one year	17	€642k
Amounts payable within one year	42/48	€236k
Trade debts payable within one year	44	€406
Income statement
Gross operating margin	9900	€50k
Operating result	9901	€15k
Financial charges	65	€17k
Result before taxes	9903	€-2k
Net result for the period	9904	€-2k
Result to be appropriated	9905	€-2k

Summary